The Latest Breaking News on Diabetes

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them

Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity-related problems like diabetes. Read further on Dynamite News:

The study noted that a vast majority of obese patients, strikingly 94.7%, received neither form of treatment, while 5% received GLP-1 RAs and 0.3% received surgery.

The researchers recommend adopting time-restricted eating as an alternative dietary strategy for diabetic patients were individualized dietary plans do not work or cannot be accessed.

Doctors are accused of placing too much focus on weight when treating women with polycystic ovary syndrome, which researchers warn is affecting quality of care.

Diagnosing diabetes before 40 quadrupled the risk of early death and later onset was linked to a one-and-a-half times higher risk of death compared with the general population without the condition.

The medicines regulator has also urged medics to warn patients of side effects.

The study reveals that even a single bout of exercise could help reduce type 2 diabetes risk factors, with benefits notable by the next day.

The proposals came from the Lords’ Food, Diet and Obesity Committee.

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

Reducing the rate of overweight and obesity in Australian kids and teenagers by five per cent could save them more than $7 billion in lifelong health costs.